|
1.
|
Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12months: Pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials. MedStar authors:
- Azizi, Viana
- Garcia-Garcia, Hector M
- Hideo-Kajita, Alexandre
- Kolm, Paul
- Ozaki, Yuichi
- Waksman, Ron
Year: 2020
Citation: - International Journal of Cardiology. 300:60-65, 2020 02 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abizaid A, Azizi V, BIOFLOW-II, BIOSOLVE-II and BIOSOLVE-III investigators, Christiansen EH, Dan K, Garcia-Garcia HM, Haude M, Hideo-Kajita A, Ince H, Kische S, Kolm P, Lefevre T, Lemos PA, Ozaki Y, Toelg R, Van Mieghem NM, Verheye S, von Birgelen C, Waksman R, Wijns W, Windecker S
|
|
2.
|
In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris - DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial. MedStar authors:
- Garcia-Garcia, Hector M
- Haude, Michael
- Hideo-Kajita, Alexandre
- Kuku, Kayode
- Waksman, Ron
Year: 2018
Citation: - International Journal of Cardiology. 255:22-28, 2018 Mar 15.
Institution: - MedStar Heart & Vascular Instituteon
Medline publication type:
All authors: - Abizaid A, Christiansen EH, Dijkstra J, Escaned J, Garcia-Garcia HM, Haude M, Hideo-Kajita A, Ince H, Kuku K, Lemos PA, Tolg R, von Birgelen C, Waksman R, Wijns W
|